isomethyleugenol has been researched along with Central Nervous System Neoplasm in 11 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 4 (36.36) | 29.6817 |
2010's | 1 (9.09) | 24.3611 |
2020's | 6 (54.55) | 2.80 |
Authors | Studies |
---|---|
Achari, RB; Das, A; Gehani, A; Hawkins, C; Ho, B; Huang, A; Lamichhane, R; Ramaswamy, V; Roy, P; Sukumaran, RK; Tabori, U; Zameer, L | 1 |
Chen, H; Deng, T; Guo, F; Huang, Q; Ling, G; Mo, L; Mu, J; Shi, L; Wu, P; Yan, J | 1 |
André, N; Basset, L; Boddaert, N; Chotard, G; Chrétien, F; Figarella-Branger, D; Girard, N; Hasty, L; Hostein, I; Jecko, V; le Loarer, F; Listrat, A; Machet, MC; Métais, A; Nicaise, Y; Rousseau, A; Scavarda, D; Tallegas, M; Tauziède-Espariat, A; Testud, B; Uro-Coste, E; Varlet, P | 1 |
Chiang, J; Furtado, LV; Li, X; Moreira, DC | 1 |
Arakawa, Y; Fukuoka, K; Hirato, J; Honda, S; Ichimura, K; Itabashi, T; Koh, K; Kurihara, J; Matsushita, Y; Mori, M; Nakazawa, A; Nobusawa, S; Tanami, Y | 1 |
Dankmeijer, L; de Ridder, J; de Witt Hamer, P; Hoving, EW; Kester, L; Kooi, EJ; Kranendonk, MEG; Pagès-Gallego, M; Tops, BBJ; van Baarsen, K; van der Lugt, J; Verburg, N; Vermeulen, C; Wesseling, P | 1 |
Farnell, BM; Kim, DS; Mayanil, CS; Shim, KW; Tomita, T; Tsurubuchi, T; Xi, G | 1 |
Laird, PW; Marczinek, K; Nürnberg, P; Rohde, K; Szymas, J; Thiel, G; Uhlmann, K; Vogel, S; Zeller, C | 1 |
Godfraind, C; Rousseau, E; Ruchoux, MM; Scaravilli, F; Vikkula, M | 1 |
Ambrosetti, A; Arrigoni, G; Capello, D; Dell'Oro, S; Ferrarese, F; Ferreri, AJ; Foppoli, M; Gaidano, G; Iuzzolino, P; Orvieto, E; Pasini, F; Ponzoni, M; Reni, M; Rossi, D | 1 |
Dong, ZQ; Ng, HK; Pang, JC; Tong, CY; Zhou, LF | 1 |
11 other study(ies) available for isomethyleugenol and Central Nervous System Neoplasm
Article | Year |
---|---|
A novel central nervous system embryonal tumor successfully treated with multi-modal therapy highlights limitation of methylation-based tumor classification.
Topics: Central Nervous System; Central Nervous System Neoplasms; Humans; Methylation; Neoplasms, Germ Cell and Embryonal; Neuroectodermal Tumors, Primitive | 2022 |
Identification of an m6A RNA Methylation Regulator Risk Score Model for Prediction of Clinical Prognosis in Astrocytoma.
Topics: Adenosine; Astrocytoma; Central Nervous System Neoplasms; Computational Biology; Databases, Genetic; Female; Gene Expression Regulation, Neoplastic; Humans; Male; Methylation; Methyltransferases; Models, Genetic; Prognosis; Proportional Hazards Models; Risk Factors; RNA Processing, Post-Transcriptional; RNA, Messenger | 2022 |
Clinicopathological and molecular characterization of three cases classified by DNA-methylation profiling as "Glioneuronal Tumors, NOS, Subtype A".
Topics: Brain Neoplasms; Central Nervous System Neoplasms; DNA; DNA Methylation; Humans; Methylation; Neoplasms, Neuroepithelial | 2022 |
Prognostic significance of chromosome arm 1q gain and methylation class in molecularly defined diffuse leptomeningeal glioneuronal tumor.
Topics: Central Nervous System Neoplasms; Chromosomes; Chromosomes, Human, Pair 1; Humans; Meningeal Neoplasms; Methylation; Neoplasms, Neuroepithelial; Prognosis | 2022 |
An infantile pineal embryonal tumor showing pathological features of a CNS ganglioneuroblastoma and the methylation profiling of an atypical teratoid/rhabdoid tumor and SMARCA4 mutation.
Topics: Brain Neoplasms; Central Nervous System Neoplasms; DNA Helicases; Ganglioneuroblastoma; Humans; Methylation; Mutation; Neoplasms, Germ Cell and Embryonal; Nuclear Proteins; Rhabdoid Tumor; SMARCB1 Protein; Teratoma; Transcription Factors | 2023 |
Ultra-fast deep-learned CNS tumour classification during surgery.
Topics: Central Nervous System Neoplasms; Child; Clinical Decision-Making; Deep Learning; Humans; Intraoperative Care; Methylation; Retrospective Studies; Sequence Analysis, DNA; Time Factors | 2023 |
Epigenetic modification after inhibition of IGF-1R signaling in human central nervous system atypical teratoid rhabdoid tumor (AT/RT).
Topics: Acetylation; Central Nervous System Neoplasms; Dose-Response Relationship, Drug; Epigenesis, Genetic; Epigenomics; Histone Acetyltransferases; Histone Deacetylases; Histones; Humans; Methylation; Podophyllotoxin; Receptor, IGF Type 1; Rhabdoid Tumor; Signal Transduction; Teratoma; Tumor Cells, Cultured | 2013 |
Distinct methylation profiles of glioma subtypes.
Topics: Adolescent; Adult; Aged; Astrocytoma; Brain; Brain Neoplasms; Central Nervous System Neoplasms; Child; Child, Preschool; CpG Islands; Female; Glioblastoma; Glioma; Humans; Infant; Male; Methylation; Middle Aged; Oligodendroglioma; Prognosis; Sulfites | 2003 |
Tumour necrosis and microvascular proliferation are associated with 9p deletion and CDKN2A alterations in 1p/19q-deleted oligodendrogliomas.
Topics: Central Nervous System Neoplasms; Chromosomes, Human, Pair 1; Chromosomes, Human, Pair 19; Chromosomes, Human, Pair 9; Gene Deletion; Genes, p16; Glioma; Humans; Loss of Heterozygosity; Methylation; Microsatellite Repeats; Necrosis; Oligodendroglioma; Polymerase Chain Reaction; Polymorphism, Single-Stranded Conformational; Promoter Regions, Genetic | 2003 |
Aberrant methylation in the promoter region of the reduced folate carrier gene is a potential mechanism of resistance to methotrexate in primary central nervous system lymphomas.
Topics: Adult; Aged; Antineoplastic Agents; Central Nervous System Neoplasms; CpG Islands; Drug Resistance, Neoplasm; Female; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Membrane Transport Proteins; Methotrexate; Methylation; Middle Aged; Predictive Value of Tests; Prevalence; Reduced Folate Carrier Protein; Reverse Transcriptase Polymerase Chain Reaction; Sequence Analysis, DNA | 2004 |
Clonality of oligoastrocytomas.
Topics: Adolescent; Adult; Astrocytoma; Central Nervous System Neoplasms; Clone Cells; Dissection; DNA Mutational Analysis; DNA, Neoplasm; Dosage Compensation, Genetic; Female; Genetic Markers; Humans; Loss of Heterozygosity; Male; Methylation; Micromanipulation; Microsatellite Repeats; Middle Aged; Polymerase Chain Reaction; Receptors, Androgen; Tumor Suppressor Protein p53 | 2002 |